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The transporters responsible for 
homeostasis
WNK1 and WNK4 (WNK, with no lysine (K)) are serine–
threonine kinases that function as molecular switches, eliciting 
coordinated eff ects on diverse ion transport pathways to 
maintain homeostasis during physiological perturbation. 
Gain-of-function mutations in either of these genes cause an 
inherited syndrome featuring hypertension and hyperkalemia 
due to increased renal NaCl reabsorption and decreased 
K+ secretion. In a paper published in PNAS, Rinehart et al. 
describe the biochemical and functional properties of WNK3, 
a related member of the WNK kinase family. Unlike WNK1 
and WNK4, WNK3 is expressed throughout the nephron, 
predominantly at intercellular junctions. Because WNK4 is a 
potent inhibitor of members of the SLC12A family of cation 
cotransporters, the authors used co-expression studies in 
Xenopus oocytes to investigate the eff ect of WNK3 on the 
Na-C cotransporters (NCC) 1 and 2, related kidney-specifi c 
transporters that mediate apical NaCl reabsorption in the thick 
ascending limb and the distal convoluted tubule, respectively. 
In contrast to WNK4’s inhibitory activity, kinase-active 
WNK3 was found to be a potent activator of both NKCC2-
mediated and NCC-mediated transport. Conversely, in its 
kinase-inactive state, WNK3 acted as a potent inhibitor of 
NCC and NKCC2 activity. WNK3 regulated the activity of 
these transporters by altering their expression at the plasma 
membrane. Wild-type WNK3 increased, and kinase-inactive 
WNK3 decreased, NKCC2 phosphorylation at Th r-184 and 
Th r-189, two sites required for the vasopressin-mediated 
plasmalemmal translocation and activation of NKCC2 in 
vivo. Th e eff ects of WNK3 on these transporters and their co-
expression in renal epithelia implicate WNK3 in NaCl, water 
and blood pressure homeostasis. (Proc Natl Acad Sci USA 2005; 
102: 16777–16782)
Juan Oliver
Chromogranin A and hypertension
Catecholamines are stored in dense core granules in 
the chromaffi  n cells of the adrenal gland. An important 
constituent of these granules are two proteins, 
chromogranins A and B. Chromogranin A (CHGA) is itself a 
prohormone that can be processed to yield several peptides. 
One of these peptides, catestatin, has been thought to inhibit 
the release of catecholamines. CHGA is overexpressed in 
people with hypertension, and catestatin is known to be low 
in people with hypertension. In a recent study, researchers 
altered levels of CHGA and catestatin in mice by deleting 
the Chga gene. Chga–/– mice had increased blood pressure 
and decreased adrenal catecholamine stores. Transgenic 
replacement of catestatin in these mice with human 
catestatin improved blood pressure. Th is research highlights 
the important role that CHGA plays in the autonomic 
control of circulation and suggests that lack of CHGA might 
underlie some cases of human hypertension. (J Clin Invest 
2005; 115: 1942–1952)
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How bladder expansion works
Epithelial cells of the bladder contain umbrella cells that 
are critical for expansion of the surface during fi lling of the 
bladder. Investigators examined the upstream signaling process 
by which the apical surface area of these cells increases when 
the bladder fi lls. An increase in fl uid pressure in rabbit bladders 
caused the uroepithelium to release adenosine triphosphate 
from the serosal side, resulting in increased membrane surface 
area as measured by electrical capacitance. Whereas addition 
of a purinergic receptor antagonist suppressed the release 
of adenosine triphosphate, purinergic receptor agonists led 
to increased membrane capacity. Mice with the purinergic 
receptors P2X2 and/or P2X3 deleted showed no response. 
Drugs that block the release of calcium from intracellular 
stores also prevented the eff ects of adenosine triphosphate. 
Th ese results show that changes in membrane surface area 
are due to transduction of the high-pressure signal to release 
adenosine triphosphate. Subsequent activation of purinergic 
receptors releases intracellular calcium, which causes 
exocytosis of membrane vesicles to the apical side, thereby 
increasing the apical surface area. (J Clin Invest 2005; 115: 
2412–2422)
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Ca permeability in the kidney. Th us, klotho activates a cell 
surface channel by hydrolysis of its extracellular N-linked 
oligosaccharides. (Science 2005; 310: 490–493)
Juan Oliver
The value of cardiac glycosides
Na,K-ATPase contains a binding site for cardiac glycosides, 
such as ouabain, digoxin and digitoxin. Although the medical 
fi eld has taken advantage of this site to treat congestive heart 
failure with drugs such as digoxin, it is unknown whether it 
has a natural function in vivo. A study by Dostanic-Larson 
et al. shows that the binding site plays an important role in 
the regulation of blood pressure; specifi cally, it mediates 
adrenocorticotropic hormone-induced hypertension in mice. 
Th e α2 isoform of Na,K-ATPase, which is normally sensitive to 
cardiac glycosides, was made resistant to these compounds and 
tested on genetically engineered mice. Chronic administration 
of adrenocorticotropic hormone caused hypertension in wild-
type mice but not in mice with an ouabain-resistant α2 isoform 
of Na,K-ATPase. Th is fi nding demonstrates that the cardiac 
glycoside binding site of Na,K-ATPase plays an important role 
in blood pressure regulation, most likely by responding to a 
naturally occurring ligand. Because the α1 isoform is sensitive 
to cardiac glycosides in humans, the authors developed mice 
in which the naturally occurring ouabain-resistant α1 isoform 
was made ouabain-sensitive. Mice with the ouabain-sensitive 
“human-like” α1 isoform and an ouabain-resistant α2 isoform 
developed adrenocorticotropic hormone-induced hypertension 
to a greater extent than wild-type mice. Th is indicates that 
the cardiac glycoside binding site of the α1 isoform can also 
mediate adrenocorticotropic hormone-induced hypertension. 
Th ese results demonstrate that the cardiac glycoside binding site 
of the α isoforms of Na,K-ATPase has a physiological function, 
and they support the hypothesis that the endogenous cardiac 
glycosides can play a role in the treatment of congestive heart 
failure. (Proc Natl Acad Sci USA 2005; 102: 15845–15850)
Juan Oliver
A new treatment for lupus?
Systemic lupus erythematosus is commonly treated with 
immunosuppressive agents including cytotoxic medications 
and corticosteroids. Several investigators are actively pursuing 
more specifi c methods that would regulate the immune 
system with less toxicity than the standard treatments. One 
mechanism involves lipid kinases, which provide a lymphocyte 
activation signal. Barber et al. examined whether inhibition 
of p110γ, a lipid kinase that is important in the infl ammatory 
cascade, reduced infl ammation without causing toxicity. 
Inhibition of p110γ with intraperitoneal AS605240 prolonged 
the lifespan of MRL-lpr mice (88% lived for 5 months) 
compared with mice in the control group treated with 
dexamethasone (50% lived for 5 months). AS605240 treatment 
also reduced phosphorylated protein kinase B levels in CD4+ 
cells, class IB (p110
γ) activity, DNA-specifi c autoantibody 
levels and mesangial proliferative glomerulonephritis, 
and it reduced or eliminated granular immune complexes. 
Proteinuria was reduced equally in the treatment and control 
groups. Treatment did not reduce tyrosine kinase or p85-
associated class IA phosphatidylinositol 3-kinase activity. Th ese 
observations demonstrate that p110γ inhibition may be a useful 
target in systemic lupus erythematosus, although the authors 
note that systemic lupus erythematosus in MRL-lpr mice is 
clinically diff erent from human systemic lupus erythematosus. 
(Nat Med 2005; 11: 933–935)
Radha McLean
How calcium balance is maintained 
in the kidney
Blood calcium (Ca) concentration is maintained within 
a narrow range despite large variations in dietary input 
and body demand. Th e Ca2+ balance is maintained by the 
concerted action of three organ systems: the gastrointestinal 
tract, bone and kidney. Th e mechanisms by which Ca2+ ions 
enter the absorptive epithelia were recently clarifi ed with the 
identifi cation of an epithelial Ca2+ channel family consisting 
of two members of the transient receptor potential (TRP) 
superfamily, TRPV5 and TRPV6. TRPV5 is predominantly 
involved in renal Ca2+ handling. Chang et al. found that mice 
lacking TRPV5 displayed diminished renal Ca2+ reabsorption, 
hypercalciuria and abnormalities in bone structure. Th e 
expression of klotho in the mouse kidney, where it is normally 
expressed abundantly, was decreased in the kidneys of TRPV5 
knockout mice. TRPV5, a β-glucuronidase, was stimulated by 
klotho. Th is hormone hydrolyzes extracellular sugar residues 
on TRPV5, entrapping the channel in the plasma membrane. 
Th is maintains durable Ca channel activity and membrane 
